Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SARILUMAB vs TOCILIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SARILUMAB vs TOCILIZUMAB: Safety Overview

Metric SARILUMAB TOCILIZUMAB
Total FAERS Reports 21,493 98,443
Deaths Reported 1,983 9,543
Death Rate 9.2% 9.7%
Hospitalizations 3,538 24,039
Average Patient Age 57.5 yrs 52.2 yrs
% Female Patients 84.4% 84.5%
Manufacturer Sanofi-Aventis U.S. LLC CELLTRION USA, Inc.
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription Prescription